Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
ENERZAIR BREEZHALER NOVARTIS PHARMACEUTICALS CANADA INC Actual shortage 160MCG 50MCG 150MCG Updated Report 2024-05-17 228307
SENSORCAINE ASPEN PHARMACARE CANADA INC. Anticipated shortage 5MG New Report 2024-05-17 228304
BIAXIN BGP PHARMA ULC Resolved 250MG Updated Report 2024-05-17 215507
MYLAN-ATOVAQUONE/PROGUANIL MYLAN PHARMACEUTICALS ULC Anticipated shortage 100MG 250MG New Report 2024-05-17 228299
OXYTOCIN INJECTION, USP FRESENIUS KABI CANADA LTD Actual shortage 10UNIT Updated Report 2024-05-17 225346
TEVA-BUPROPION XL TEVA CANADA LIMITED Actual shortage 300MG Updated Report 2024-05-17 223856
TEVA-BUPROPION XL TEVA CANADA LIMITED Actual shortage 300MG Updated Report 2024-05-17 224445
LITHMAX AA PHARMA INC Actual shortage 300MG Updated Report 2024-05-17 221857
SENSORCAINE ASPEN PHARMACARE CANADA INC. Anticipated shortage 5MG Updated Report 2024-05-17 222686
SENSORCAINE WITH EPINEPHRINE ASPEN PHARMACARE CANADA INC. Anticipated shortage 5MCG 2.5MG New Report 2024-05-17 228282

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
SANDOZ SENNA S SANDOZ CANADA INCORPORATED To be discontinued 50MG 8.6MG New Report 2024-05-17 228268
SANDOZ PRAVASTATIN TABLETS SANDOZ CANADA INCORPORATED To be discontinued 40MG New Report 2024-05-17 228263
SANDOZ PRAVASTATIN TABLETS SANDOZ CANADA INCORPORATED To be discontinued 20MG New Report 2024-05-17 228256
HEPARIN SODIUM INJECTION USP (MULTIDOSE VIAL-WITH PRESERVATIVE) SANDOZ CANADA INCORPORATED To be discontinued 10000UNIT New Report 2024-05-17 228249
SUPREFACT DEPOT 3 MONTHS CHEPLAPHARM ARZNEIMITTEL GMBH Discontinued 9.45MG Updated Report 2024-05-17 228166